In this document, PATH seeks to synthesize primary scientific literature, technology landscape analyses, and drug development principles to describe key considerations related to the diagnosis and control of schistosomiasis and outline a business case for financing, developing, and deploying new diagnostics for detection of Schistosoma infection.
Corporate author(s): PATH
Publication date: 2016
1,999 KB PDF
Hard copies are not available.
Some digital files may be saved at low resolutions to conserve file size. Versions with higher quality may be available; see the contact information below to enquire.
For more information…
Contact: PATH Publications
Mailing address: PATH, PO Box 900922, Seattle, WA 98109 USA